Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT07324785, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Northern Jiangsu People's Hospital
- Trial code
- NCT07324785
- Record updated
- 17 February 2026
- Original description
This study is a prospective observational study. The study will explore the correlation between advanced glycation end products and gastric motility disorder in diabetic gastroparesis（DGP) through the collection of blood and gastric tissue samples and relevant data of patients with DGP and control group patients without diabetes history and gastroparesis symptoms.Read full original descriptionShow less
The Role and Mechanism of SphK1/S1P/FOXO1 Axis Regulating KATP Channel Mediated Gastric Smooth Muscle Dysfunction in Diabetes Gastroparesis
This study is a prospective observational study. The study will explore the correlation between advanced glycation end products and gastric motility disorder in diabetic gastroparesis（DGP) through the collection of blood and gastric tissue samples and relevant data of patients with DGP and control group patients without diabetes history and gastroparesis symptoms.
Inclusion: Meet the diagnostic criteria for diabetes; Presence of symptoms (see assessment of Gastroparesis Cardinal Symptom Index); Age range from 18 to 75 years old; Voluntarily participate and sign an informed consent form; No history of diabetes; No symptoms (see assessment of Gastroparesis Cardinal Symptom Index); Age range from 18 to 75 years old; Voluntarily participate and sign an informed consent form.
Exclusion: Currently taking prokinetic drugs, anticholinergic drugs, and dopamine drugs that may affect gastric motility; Has a history of gastrointestinal surgery; There are neurological disorders such as Parkinson's disease that affect gastrointestinal function; Pregnant or preparing to conceive; Outlet obstruction caused by organic lesions in the pylorus.